Vénissieux, France

Aurélien Traversier

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aurélien Traversier: Innovator in Vaccine Antigen Preparation

Introduction

Aurélien Traversier is a notable inventor based in Vénissieux, France. He has made significant contributions to the field of vaccine development, particularly through his innovative methods for preparing vaccine antigens. His work is essential in the ongoing fight against infectious diseases.

Latest Patents

Aurélien Traversier holds a patent for a method for preparing a vaccine antigen. This patent, titled "Method for preparing a vaccine antigen, resulting vaccine antigen and uses," describes a process that involves fragmenting a biological membrane associated with the vaccine antigen. The method utilizes at least one calixarene of a specific formula, resulting in a vaccine antigen that includes a fragment of the biological membrane. The invention also details the production of a vaccine that incorporates this method, which can be used as a drug for treating or preventing infectious diseases.

Career Highlights

Throughout his career, Aurélien Traversier has worked with prominent organizations such as Calixar and Université Claude Bernard Lyon 1. His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research and development efforts.

Collaborations

Some of Aurélien's notable coworkers include Manuel Rosa-Calatrava and Élodie Desuzinges-Mandon. Their collaborative efforts have contributed to advancements in vaccine research and development.

Conclusion

Aurélien Traversier's innovative work in vaccine antigen preparation showcases his commitment to improving public health. His contributions are vital in the ongoing battle against infectious diseases, and his patent reflects the potential for significant advancements in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…